Cronos (CRON) Return on Capital Employed (2020 - 2026)
Cronos' (CRON) quarterly Return on Capital Employed came in at 1.33% in Q1 2026, up 441.0% year-on-year from 0.25% in Q1 2025, and up 13.07% quarter-over-quarter from 1.53% in Q4 2025.
Cronos (CRON) Return on Capital Employed (2020 - 2026) Analysis & Trends
Cronos' Return on Capital Employed history runs 7 years deep, the most recent figure standing at 1.33% for Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 441.0% year-over-year to 1.33% in Q1 2026; TTM through Mar 2026 was 1.33%, a 441.0% increase from a year earlier, with the FY2025 full-year figure at 1.53%, up 540.0% from the prior year.
- Return on Capital Employed climbed to 1.33% in Q1 2026 per CRON's latest filing, from 1.53% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 1.39% in Q3 2022 and bottomed at 21.04% in Q1 2022.
- The 5-year median for Return on Capital Employed is 7.02% (2024), against an average of 6.3%.
- Across the five-year window, Return on Capital Employed surged 3183 bps in 2022 and plunged 938 bps in 2023, its largest moves.
- Year by year, Return on Capital Employed stood at 9.49% in 2022, then advanced by 19 bps to 7.68% in 2023, then gained by 11 bps to 6.8% in 2024, then surged by 78 bps to 1.53% in 2025, then grew by 13 bps to 1.33% in 2026.
- Per Business Quant, the three latest CRON Return on Capital Employed figures stand at 1.33% (Q1 2026), 1.53% (Q4 2025), and 1.87% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 27.36% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.50% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.43% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.46% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 20.04% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.24% |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | -1.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.33% |
| Dec 31, 2025 | -1.53% |
| Sep 30, 2025 | -1.87% |
| Jun 30, 2025 | -4.83% |
| Mar 31, 2025 | -5.74% |
| Dec 31, 2024 | -6.80% |
| Sep 30, 2024 | -7.91% |
| Jun 30, 2024 | -7.02% |
| Mar 31, 2024 | -7.33% |
| Dec 31, 2023 | -7.68% |
| Sep 30, 2023 | -7.99% |
| Jun 30, 2023 | -8.43% |
| Mar 31, 2023 | -8.68% |
| Dec 31, 2022 | -9.49% |
| Sep 30, 2022 | 1.39% |
| Jun 30, 2022 | -0.90% |
| Mar 31, 2022 | -21.04% |
| Dec 31, 2021 | -20.09% |
| Sep 30, 2021 | -30.44% |
| Jun 30, 2021 | -28.62% |